UnitedHealth Group Incorporated filings document the formal disclosures of a large health care company organized around UnitedHealthcare and Optum. Proxy materials describe board governance, executive compensation, shareholder voting matters and the company’s complementary businesses: UnitedHealthcare health coverage and Optum clinical, data, product, pharmacy and care services.
Current reports on Form 8-K cover operating and financial results, Regulation FD communications, strategy and market-position discussions, director appointments, compensation arrangements and other material-event disclosures. The filing record also documents governance practices, capital-structure and compensation matters, risk-related business context and the regulatory reporting framework for a Delaware public operating company in the health care sector.
UnitedHealth Group director reports quarterly equity compensation. Director John H. Noseworthy M.D., a board member of UnitedHealth Group Inc., reported receiving 261 shares of common stock on 01/02/2026 at a stated price of $0.
According to the disclosure, these are deferred stock units granted as regular quarterly compensation for service as a director. The units are immediately vested but must be held until the director’s service on the Board is completed. After this grant, the director beneficially owns 6,997 shares directly.
UnitedHealth Group director reports quarterly equity grant
A director of UnitedHealth Group received 279 deferred stock units of common stock on 01/02/2026 as regular quarterly compensation for Board service. These deferred stock units vest immediately but must be held until the director’s service on the Board is completed. Following this grant, the director beneficially owns a total of 7,219 shares or units of UnitedHealth Group common stock, held directly.
UnitedHealth Group director reports quarterly deferred stock grant
A UnitedHealth Group director reported receiving 125 deferred stock units of common stock on January 2, 2026 as regular quarterly compensation for Board service. The filing states these deferred stock units are immediately vested but must be held until the director completes service on the Board. After this grant, the director beneficially owns 125 shares in direct form.
UnitedHealth Group director Michele J. Hooper reported receiving 168 deferred stock units of UnitedHealth Group common stock on 01/02/2026 as regular quarterly compensation for service on the Board. These deferred stock units were granted at a price of $0, are immediately vested, and must be retained until she completes her service as a director. Following this grant, she beneficially owns 41,294 shares of UnitedHealth Group common stock in direct ownership.
UnitedHealth Group director reports quarterly stock compensation. Director Frederick William McNabb III received 316 deferred stock units of UnitedHealth Group common stock on 01/02/2026 at a price of $0, reflecting regular quarterly compensation for board service. Following this grant, he beneficially owns 14,710 shares/units of common stock.
The filing explains that these deferred stock units are immediately vested but must be held until the director completes service on the Board. The report is filed as a Form 4 by a single reporting person and reflects a routine equity-based compensation award for a non-employee director.
UnitedHealth Group Inc. director Charles D. Baker reported a routine equity compensation transaction. On 01/02/2026, he acquired 279 deferred stock units of UnitedHealth Group common stock at a price of $0 per unit. These deferred stock units are granted as regular quarterly compensation for service as a director and are immediately vested, but must be retained until he completes his service on the Board. Following this grant, he beneficially owns 1,806 shares/deferred stock units on a direct basis.
UnitedHealth Group CEO and director Stephen J. Hemsley reported a gift of company stock. On 12/19/2025, he conveyed 55,000 shares of UnitedHealth Group common stock as a gift at a reported price of $0. After this transaction, he beneficially owned 372,947.942 shares directly. He also held 351.9396 shares indirectly through a 401(k) plan and 681,875 shares indirectly through trusts. The filing indicates this was a personal share transfer rather than an open‑market sale.
UnitedHealth Group executive reports routine share accrual from dividends. Timothy J. Noel, Chief Executive Officer of UnitedHealthcare (a unit of UnitedHealth Group Inc.), reported acquiring 44.329 shares of UnitedHealth Group common stock on 12/16/2025. The filing explains this represents dividend equivalents paid on outstanding restricted stock units, which follow the same vesting terms as the underlying awards and are forfeited if those units do not vest.
These shares were acquired at a price of $0, reflecting that they are dividend-related accruals rather than open-market purchases. Following this transaction, Noel directly beneficially owns 9,330.668 shares of UnitedHealth Group common stock.
UnitedHealth Group director reports stock credited from dividend equivalents. On 12/16/2025, a director of UnitedHealth Group Inc. received 43 shares of common stock at a price of $0. These shares represent dividend equivalents paid on vested deferred stock units, and are immediately vested under the same terms as the underlying deferred stock units.
Following this transaction, the director beneficially owns 6,940 shares of UnitedHealth Group common stock in direct form.
UnitedHealth Group executive reports routine share accrual tied to awards
UnitedHealth Group executive Erin L. McSweeney, EVP & Chief People Officer, reported an acquisition of 38.566 shares of UnitedHealth Group common stock on 12/16/2025. The filing explains that this amount represents dividend equivalents paid on outstanding restricted stock units, which follow the same vesting terms as the underlying awards and are forfeited if those units do not vest. After this transaction, McSweeney beneficially owned a total of 11,192.638 shares of common stock in direct form.